日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer

一项针对新诊断为雌激素受体或孕激素受体阳性乳腺癌的绝经后女性患者的术前(新辅助)来曲唑联合贝伐单抗的试点试验

Forero-Torres, Andres; Saleh, Mansoor N; Galleshaw, Janice A; Jones, Cheryl F; Shah, Jatin J; Percent, Ivor J; Nabell, Lisle M; Carpenter, John T; Falkson, Carla I; Krontiras, Helen; Urist, Marshall M; Bland, Kirby I; De Los Santos, Jennifer F; Meredith, Ruby F; Caterinicchia, Valerie; Bernreuter, Wanda K; O'Malley, Janis P; Li, Yufeng; LoBuglio, Albert F